Jo Howard
Impact in
- Genetics top 0.2%
- Hemoglobinopathies and Related Disorders
- Hematology top 5%
- Blood groups and transfusion
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Genetics 90
- Hemoglobinopathies and Related Disorders 90
-
- Blood groups and transfusion 2
- Co-authors
- Eugene Oteng‐Ntim (13 shared papers)Swee Lay Thein (14 shared papers)Ashley P Jones (1 shared paper)Sarah J Nevitt (1 shared paper)Moji Awogbade (12 shared papers)Sally C. Davies (9 shared papers)Baba P. D. Inusa (15 shared papers)Susan E. Robinson (8 shared papers)
- Journals
- Blood (19 papers)British Journal of Haematology (18 papers)Blood Advances (4 papers)Trials (4 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Jo Howard
111 papers receiving 3.4k citations
Jo Howard's Hit Papers
Peers
Comparison fields: 5 of 73
- Genetics 2.4k
- Hematology 268
- Biochemistry 51
- Management of Technology and Innovation 23
- Family Practice 6
Countries citing papers authored by Jo Howard
This map shows the geographic impact of Jo Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Howard more than expected).
Fields of papers citing papers by Jo Howard
This network shows the impact of papers produced by Jo Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Howard. The network helps show where Jo Howard may publish in the future.
Co-authors
The 25 scholars most cited alongside Jo Howard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease Hit paper breakdown → | 2019 | 479 |
| 2 | American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support Hit paper breakdown → | 2020 | 331 |
| 3 | 2010 | 212 | |
| 4 | 2013 | 174 | |
| 5 | 2017 | 138 | |
| 6 | 2015 | 132 | |
| 7 | 2016 | 132 | |
| 8 | 2002 | 130 | |
| 9 | 2019 | 101 | |
| 10 | 2014 | 84 | |
| 11 | 2021 | 81 | |
| 12 | 2018 | 72 | |
| 13 | 2011 | 71 | |
| 14 | 2018 | 68 | |
| 15 | 2021 | 66 | |
| 16 | 2018 | 63 | |
| 17 | 2005 | 52 | |
| 18 | 2010 | 51 | |
| 19 | 2007 | 49 | |
| 20 | 2015 | 48 |
About Jo Howard
Jo Howard is a scholar working on Genetics, Hematology, Speech and Hearing, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 114 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (90 papers), Blood groups and transfusion (2 papers), Advanced MRI Techniques and Applications (2 papers), Adolescent and Pediatric Healthcare (1 paper), Cardiovascular Issues in Pregnancy (1 paper), Orthopaedic implants and arthroplasty (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper) and Sexual function and dysfunction studies (1 paper). The work is most often cited by research in Genetics (2.4k citations), Hematology (268 citations), Biochemistry (51 citations), Management of Technology and Innovation (23 citations) and Family Practice (6 citations). Jo Howard has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Eugene Oteng‐Ntim, Swee Lay Thein, Ashley P Jones, Sarah J Nevitt, Moji Awogbade, Sally C. Davies, Baba P. D. Inusa, Susan E. Robinson, David C. Rees and H. Grant Prentice. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, Trials and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.